947401-26-5Relevant articles and documents
CANCER IMAGING AND TREATMENT
-
Paragraph 0123; 0124, (2014/02/16)
A compound, or a pharmaceutically acceptable salt or ester thereof, comprises the structure: [in-line-formulae][(P1-S1j)p-L-(S2q-P2)r]t [/in-line-formulae] wherein: P1 and P2, which may be the same or
Studies directed toward the synthesis of naturally occurring acyltetramic acids. 2. Preparation of the macrocyclic subunit of ikarugamycin
Boeckman Jr.,Perni
, p. 5486 - 5489 (2007/10/02)
-